BATTAGLIA MARIO ALBERTO | Elenco docenti

Sormani, M.P., Schiavetti, I., Carmisciano, L., Cordioli, C., Filippi, M., Radaelli, M., et al. (2022). COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context. NEUROLOGY® NEUROIMMUNOLOGY & NEUROINFLAMMATION, 9(1) [10.1212/NXI.0000000000001105]. - dettaglio
Sormani, M.P., De Rossi, N., Schiavetti, I., Carmisciano, L., Cordioli, C., Moiola, L., et al. (2021). Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis. ANNALS OF NEUROLOGY, 89(4), 780-789. - dettaglio
Lepore, V., Bosetti, C., Santucci, C., Iaffaldano, P., Trojano, M., Mosconi, P., et al. (2021). Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register. EUROPEAN JOURNAL OF NEUROLOGY, 28(2), 567-578 [10.1111/ene.14589]. - dettaglio
Prada, V., Tacchino, A., Podda, J., Pedullá, L., Konrad, G., Battaglia, M.A., et al. (2021). Mam36 and Abilhand as outcome measures of multiple sclerosis hand disability: an observational study. EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE, 57(4), 520-526 [10.23736/S1973-9087.20.06446-1]. - dettaglio
Alessandro Maglione, A.D.S., Signori, A., Laroni, A., Iovino, A., Repice, A.M., Mannironi, A., et al. (2021). Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies. EBIOMEDICINE, 72 [10.1016/j.ebiom.2021.103581]. - dettaglio